CDT EQUITY INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CDT EQUITY INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $8.17M.
- CDT EQUITY INC. stock issued during period, value, new issues for the quarter ending 2024-12-31 was -$1.00K.
- CDT EQUITY INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $1.57M, a 92.07% decline year-over-year.
- CDT EQUITY INC. stock issued during period, value, new issues for the quarter ending 2023-12-31 was $0.00.
- CDT EQUITY INC. stock issued during period, value, new issues for fiscal 2023 was $19.78M, a 163.01% increase from fiscal 2022.
- CDT EQUITY INC. stock issued during period, value, new issues for fiscal 2022 was $7.52M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-03-31 | $8.17M 10-Q/A · filed 2025-08-14 | |
| 2024-12-31 | -$1.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-09-08 | $1.57M S-1 · filed 2026-09-08 |
| 2024-09-30 | $1.57M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | $19.78M 10-K · filed 2024-04-16 |
| 2023-09-30 | $19.78M 10-Q/A · filed 2023-11-21 | |
| 2022-12-31 | $7.52M 10-K · filed 2023-03-28 | |
| 2022-03-31 | $7.52M 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |